Journal profile · Biochemistry & Molecular Biology
Human Molecular Genetics
ISSN 0964-6906 · eISSN 1460-2083 · Oxford University Press · ENGLAND · Semimonthly · Founded 1992
Human Molecular Genetics: CAS Zone 2 · Biology (2025 upgraded edition); impact factor 3.11; hybrid open access; APC about USD 4,390; median 130 days to acceptance (105 articles, last 24 months); community-reported acceptance: fairly hard; 210 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Human Molecular Genetics is published by Oxford University Press and is in Zone 2 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Mitochondrial Function and Pathology, Genetic Neurodegenerative Diseases and Genetics and Neurodevelopmental Disorders, together about 22.3% of its articles. Its main subfields are Molecular Biology and Genetics. (generated from OpenAlex topic counts and CAS ranking data)
Human Molecular Genetics concentrates on full-length research papers covering a wide range of topics in all aspects of human molecular genetics. These include: the molecular basis of human genetic disease developmental genetics cancer genetics neurogenetics chromosome and genome structure and function therapy of genetic disease stem cells in human genetic disease and therapy, including the application of iPS cells genome-wide association studies mouse and other models of human diseases functional genomics computational genomics In addition, the journal also publishes research on other model systems for the analysis of genes, especially when there is an obvious relevance to human genetics.
Source: LetPub
Research area (LetPub): Biochemistry & Molecular Biology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Mitochondrial Function and PathologyBiochemistry, Genetics and Molecular Biology7.9%
- Genetic Neurodegenerative DiseasesNeuroscience7.9%
- Genetics and Neurodevelopmental DisordersBiochemistry, Genetics and Molecular Biology6.5%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology6.3%
- RNA Research and SplicingBiochemistry, Genetics and Molecular Biology5.9%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology5.5%
- Muscle Physiology and DisordersBiochemistry, Genetics and Molecular Biology5.3%
- Genetic Associations and EpidemiologyBiochemistry, Genetics and Molecular Biology4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Genetics & Heredity | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Biochemistry & Molecular Biology | Zone 2 |
| Minor | Genetics & Heredity | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Genetics & Heredity | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.11LetPub ·
- CiteScore 2026-06
- 7.2LetPub ·
- SJR 2026-06
- 1.45LetPub ·
- SNIP 2026-06
- 1LetPub ·
- h-index
- 255LetPub ·
- h-index
- 360OpenAlex ·
- i10-index
- 11,594OpenAlex ·
- 2-year mean citedness
- 3.19OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 42.52%LetPub ·
Volume
- Articles per year
- 182LetPub ·
Articles by year OpenAlex count · 14,224 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 101 | 61 | 16 |
| 2025 | 210 | 131 | 475 |
| 2024 | 192 | 163 | 1,116 |
| 2023 | 209 | 185 | 2,207 |
| 2022 | 311 | 252 | 5,134 |
| 2021 | 376 | 299 | 8,155 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
130 daysMedian, submission to acceptance · P25–P75 96 days – 171 days
- Acceptance to online
- median 170 days (1 articles)
- Submission to online
- median 417 days
- Sample
- 105 articles with submission and acceptance dates (396 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 2–4 weeksLetPub ·
- Average acceptance (community reports)
- Fairly hardLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,390 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Oxford University Press
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Semimonthly
- Founded
- 1992
- ISSN
- 0964-6906
- Electronic ISSN
- 1460-2083
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Human Molecular Genetics
What CAS zone is Human Molecular Genetics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Human Molecular Genetics is in Zone 2 of Biology, and in Zone 3 of the minor category Biochemistry & Molecular Biology / Genetics & Heredity. In the 2026 Xinrui edition it is in Zone 2 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Human Molecular Genetics?
The latest impact factor listed by LetPub is 3.11; CiteScore 7.2, h-index 360.
How long does peer review take at Human Molecular Genetics?
Based on the dates recorded on 105 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 130 days (interquartile range 96–171 days); authors report an average review time of 2–4 weeks; the community-reported acceptance is “Fairly hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Human Molecular Genetics?
According to LetPub and DOAJ records, Human Molecular Genetics is indexed in SCIE and Scopus.
Is Human Molecular Genetics open access, and what is the APC?
Human Molecular Genetics is a hybrid journal. For open-access publication: APC about USD 4,390.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .